![A trial looking at lenalidomide (Revlimid) for B cell chronic lymphocytic leukaemia that has responded to second line chemotherapy (The CONTINUUM Trial) | Cancer Research UK A trial looking at lenalidomide (Revlimid) for B cell chronic lymphocytic leukaemia that has responded to second line chemotherapy (The CONTINUUM Trial) | Cancer Research UK](https://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/4289-randomisation.png?itok=0U5bPH8K)
A trial looking at lenalidomide (Revlimid) for B cell chronic lymphocytic leukaemia that has responded to second line chemotherapy (The CONTINUUM Trial) | Cancer Research UK
![Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1756-8722-2-36/MediaObjects/13045_2009_Article_63_Fig3_HTML.jpg)
Mechanism of action of lenalidomide in hematological malignancies | Journal of Hematology & Oncology | Full Text
![Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma - Lund - 2018 - Cancer Medicine - Wiley Online Library Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma - Lund - 2018 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/91b0943e-1019-4df5-8dc3-8dcc37d2b5ef/cam41422-toc-0001-m.jpg?trick=1705860501904)